Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV

[1]  I. Grant,et al.  Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease , 2020, Brain, Behavior, and Immunity.

[2]  R. Heaton,et al.  Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV , 2020, Brain, behavior, & immunity - health.

[3]  C. Nemeroff,et al.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble , 2020, Neuron.

[4]  I. Grant,et al.  Cumulative Burden of Depression and Neurocognitive Decline among Persons with HIV: A Longitudinal Study. , 2020, Journal of acquired immune deficiency syndromes.

[5]  D. Jeste,et al.  Pre-frailty predicts cognitive decline at 2-year follow-up in persons living with HIV , 2019, Journal of NeuroVirology.

[6]  T. Burdo,et al.  HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression? , 2019, Front. Aging Neurosci..

[7]  E. Sinforiani,et al.  Cognitive impairment in depression: recent advances and novel treatments , 2019, Neuropsychiatric disease and treatment.

[8]  D. Jeste,et al.  Depression and aging with HIV: Associations with health-related quality of life and positive psychological factors. , 2019, Journal of affective disorders.

[9]  Y. Mizoguchi,et al.  Low-Grade Inflammation Is Associated with Apathy Indirectly via Deep White Matter Lesions in Community-Dwelling Older Adults: The Sefuri Study , 2019, International journal of molecular sciences.

[10]  D. Knopman,et al.  Systemic inflammation during midlife and cognitive change over 20 years , 2019, Neurology.

[11]  L. Rubin,et al.  HIV, Depression, and Cognitive Impairment in the Era of Effective Antiretroviral Therapy , 2019, Current HIV/AIDS Reports.

[12]  Jessica L. Montoya,et al.  Inflammation Relates to Poorer Complex Motor Performance Among Adults Living With HIV on Suppressive Antiretroviral Therapy , 2019, Journal of acquired immune deficiency syndromes.

[13]  R. McIntyre,et al.  Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression , 2018, Therapeutic advances in psychopharmacology.

[14]  D. Goldsmith,et al.  Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder , 2018, Psychoneuroendocrinology.

[15]  D. Goldsmith,et al.  What does plasma CRP tell us about peripheral and central inflammation in depression? , 2018, Molecular Psychiatry.

[16]  D. Jeste,et al.  Neurocognitive functioning predicts frailty index in HIV , 2018, Neurology.

[17]  M. Young,et al.  Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study , 2018, Journal of NeuroVirology.

[18]  Wuxiang Xie,et al.  High-sensitivity C-reactive protein and cognitive decline: the English Longitudinal Study of Ageing , 2017, Psychological Medicine.

[19]  M. Trivedi,et al.  Is C-reactive protein ready for prime time in the selection of antidepressant medications? , 2017, Psychoneuroendocrinology.

[20]  J. Felger.  The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications. , 2016, Current topics in behavioral neurosciences.

[21]  M. Treadway,et al.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine , 2017, Neuropsychopharmacology.

[22]  A. Miller,et al.  Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression , 2016, Molecular Psychiatry.

[23]  Xiaoping P. Hu,et al.  Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression , 2015, Molecular Psychiatry.

[24]  Andrew H. Miller,et al.  The role of inflammation in depression: from evolutionary imperative to modern treatment target , 2015, Nature Reviews Immunology.

[25]  C. Mussi,et al.  A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity , 2015, AIDS.

[26]  Robert K. Heaton,et al.  HIV Infection Is Associated with Attenuated Frontostriatal Intrinsic Connectivity: A Preliminary Study , 2015, Journal of the International Neuropsychological Society.

[27]  J. Cauley,et al.  Trajectories of inflammatory markers and cognitive decline over 10 years , 2014, Neurobiology of Aging.

[28]  J. Kramer,et al.  Longitudinal Inflammation, Cognitive Decline, and Alzheimer's Disease: A Mini‐Review , 2014, Clinical pharmacology and therapeutics.

[29]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[30]  D. Douek,et al.  Systemic effects of inflammation on health during chronic HIV infection. , 2013, Immunity.

[31]  D. Blacker,et al.  The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[32]  Michael J. Taylor,et al.  Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change , 2011, Journal of clinical and experimental neuropsychology.

[33]  M. Trivedi,et al.  Psychometric evaluation of the Snaith–Hamilton pleasure scale in adult outpatients with major depressive disorder , 2010, International clinical psychopharmacology.

[34]  I. Grant,et al.  Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders , 2009, Neuropsychology Review.

[35]  J. Rabkin.  HIV and depression: 2008 review and update , 2008, Current HIV/AIDS reports.

[36]  J. Leserman.  Role of depression, stress, and trauma in HIV disease progression. , 2008, Psychosomatic medicine.

[37]  W. Miller,et al.  Prevalence and Comorbidity of Psychiatric Diagnoses Based on Reference Standard in an HIV+ Patient Population , 2008, Psychosomatic medicine.

[38]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[39]  Daniel J. Bauer,et al.  Computational Tools for Probing Interactions in Multiple Linear Regression, Multilevel Modeling, and Latent Curve Analysis , 2006 .

[40]  Robert K. Heaton,et al.  Predictive Validity of Global Deficit Scores in Detecting Neuropsychological Impairment in HIV Infection , 2004, Journal of clinical and experimental neuropsychology.

[41]  小嶋 雅代,et al.  日本語版 Beck Depression Inventory-II (BDI-II) の開発 , 2002 .

[42]  C. Sherbourne,et al.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. , 2001, Archives of general psychiatry.

[43]  J. Neyman,et al.  Tests of certain linear hypotheses and their application to some educational problems. , 1936 .